A detailed history of Guggenheim Capital LLC transactions in Baxter International Inc stock. As of the latest transaction made, Guggenheim Capital LLC holds 19,017 shares of BAX stock, worth $636,308. This represents 0.01% of its overall portfolio holdings.

Number of Shares
19,017
Previous 122,686 84.5%
Holding current value
$636,308
Previous $4.1 Million 82.4%
% of portfolio
0.01%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$32.85 - $40.26 $3.41 Million - $4.17 Million
-103,669 Reduced 84.5%
19,017 $722,000
Q2 2024

Aug 14, 2024

SELL
$32.87 - $43.55 $429,413 - $568,937
-13,064 Reduced 9.62%
122,686 $4.1 Million
Q1 2024

May 14, 2024

SELL
$37.88 - $43.77 $911,317 - $1.05 Million
-24,058 Reduced 15.05%
135,750 $5.8 Million
Q4 2023

Feb 14, 2024

BUY
$31.71 - $38.95 $278,604 - $342,214
8,786 Added 5.82%
159,808 $6.18 Million
Q3 2023

Nov 14, 2023

SELL
$37.32 - $49.29 $471,202 - $622,335
-12,626 Reduced 7.72%
151,022 $5.7 Million
Q2 2023

Aug 11, 2023

SELL
$39.98 - $47.68 $576,031 - $686,973
-14,408 Reduced 8.09%
163,648 $7.46 Million
Q1 2023

May 10, 2023

SELL
$37.58 - $52.57 $607,555 - $849,899
-16,167 Reduced 8.32%
178,056 $7.22 Million
Q4 2022

Feb 14, 2023

BUY
$49.7 - $57.71 $655,543 - $761,194
13,190 Added 7.29%
194,223 $9.9 Million
Q3 2022

Nov 14, 2022

BUY
$53.86 - $66.8 $1.81 Million - $2.24 Million
33,562 Added 22.76%
181,033 $9.75 Million
Q2 2022

Aug 15, 2022

BUY
$63.83 - $80.0 $616,023 - $772,080
9,651 Added 7.0%
147,471 $9.47 Million
Q1 2022

May 16, 2022

BUY
$76.85 - $89.45 $559,006 - $650,659
7,274 Added 5.57%
137,820 $10.7 Million
Q4 2021

Feb 14, 2022

BUY
$74.57 - $87.19 $1.67 Million - $1.95 Million
22,359 Added 20.67%
130,546 $11.2 Million
Q3 2021

Nov 15, 2021

BUY
$73.77 - $83.61 $1.69 Million - $1.91 Million
22,894 Added 26.84%
108,187 $8.7 Million
Q2 2021

Aug 13, 2021

BUY
$80.5 - $88.01 $1.43 Million - $1.56 Million
17,723 Added 26.23%
85,293 $6.87 Million
Q1 2021

May 13, 2021

BUY
$76.38 - $86.03 $468,056 - $527,191
6,128 Added 9.97%
67,570 $5.7 Million
Q4 2020

Feb 16, 2021

BUY
$75.39 - $82.36 $1.75 Million - $1.91 Million
23,209 Added 60.7%
61,442 $4.93 Million
Q3 2020

Nov 13, 2020

SELL
$78.33 - $90.73 $936,748 - $1.09 Million
-11,959 Reduced 23.83%
38,233 $3.07 Million
Q2 2020

Aug 14, 2020

SELL
$78.66 - $94.14 $1.61 Million - $1.93 Million
-20,458 Reduced 28.96%
50,192 $4.32 Million
Q1 2020

Jun 02, 2020

SELL
$71.57 - $93.3 $2.61 Million - $3.4 Million
-36,488 Reduced 34.06%
70,650 $5.74 Million
Q4 2019

Feb 14, 2020

BUY
$76.7 - $88.45 $1.72 Million - $1.98 Million
22,378 Added 26.4%
107,138 $8.96 Million
Q3 2019

Nov 14, 2019

SELL
$81.4 - $89.78 $1.5 Million - $1.66 Million
-18,436 Reduced 17.87%
84,760 $7.41 Million
Q2 2019

Aug 14, 2019

BUY
$73.44 - $82.41 $599,857 - $673,124
8,168 Added 8.6%
103,196 $8.45 Million
Q1 2019

May 15, 2019

SELL
$64.48 - $81.31 $1.68 Million - $2.12 Million
-26,058 Reduced 21.52%
95,028 $7.73 Million
Q4 2018

Feb 14, 2019

BUY
$61.45 - $77.8 $269,212 - $340,841
4,381 Added 3.75%
121,086 $7.97 Million
Q3 2018

Nov 14, 2018

BUY
$70.71 - $77.75 $618,641 - $680,234
8,749 Added 8.1%
116,705 $9 Million
Q2 2018

Aug 14, 2018

SELL
$63.43 - $75.41 $38 Million - $45.2 Million
-599,625 Reduced 84.74%
107,956 $7.97 Million
Q1 2018

May 15, 2018

SELL
$62.56 - $72.26 $4.62 Million - $5.33 Million
-73,799 Reduced 9.44%
707,581 $46 Million
Q4 2017

Feb 14, 2018

BUY
$61.45 - $66.05 $1.82 Million - $1.96 Million
29,668 Added 3.95%
781,380 $50.5 Million
Q3 2017

Nov 14, 2017

BUY
$59.5 - $64.61 $44.7 Million - $48.6 Million
751,712
751,712 $47.2 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.9B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.